An experimental model of partial insulin-like growth factor-1 deficiency in mice

Author： Castilla-Cortazar I. Guerra L. Puche J. Muñoz U. Barhoum R. Escudero E. Lavandera J.

ISSN： 1138-7548

Source： Journal of Physiology and Biochemistry, Vol.70, Iss.1, 2014-03, pp. : 129-139

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

The Expression of Insulin-like Growth Factor-1 during Adipogenesisin Vivo:Effect of Thyroxine

By Kim H.S. Richardson R.L. Hausman G.J.

General and Comparative Endocrinology, Vol. 112, Iss. 1, 1998-10 ,pp. : 38-45

Elsevier

Access to resources Recommend Favorite

Paraquat induces apoptosis in human lymphocytes: Protective and rescue effects of glucose, cannabinoids and insulin-like growth factor-1

By Rio Marlene Jimenez Del Velez-Pardo Carlos

Growth Factors, Vol. 26, Iss. 1, 2008-03 ,pp. : 49-60

Informa Healthcare

Access to resources Recommend Favorite

Evaluation of insulin-like growth factor-1 for prevention of radiation-induced spinal cord damage

By Nieder Carsten Andratschke Nicolaus Price Roger E. Rivera Belinda Kian Ang K.

Growth Factors, Vol. 23, Iss. 1, 2005-03 ,pp. : 15-18

Informa Healthcare

Access to resources Recommend Favorite

Insulin-like growth factor-2 (IGF-2) activates estrogen receptor-αα and -ββ via the IGF-1 and the insulin receptors in breast cancer cells

By Richardson A. E. Hamilton N. Davis W. Brito C. De Leóón D.

Growth Factors, Vol. 29, Iss. 2-3, 2011-04 ,pp. : 82-93

Informa Healthcare

Access to resources Recommend Favorite

Heparin-binding EGF-like growth factor (HB-EGF) overexpression in transgenic mice downregulates insulin-like growth factor binding protein (IGFBP)-3 and -4 mRNA

By Provenzano Aaron P. Besner Gail E. James Paul F. Harding Paul A.

Growth Factors, Vol. 23, Iss. 1, 2005-03 ,pp. : 19-31

Informa Healthcare

Access to resources Recommend Favorite